BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1
99 results:

  • 1. Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas.
    Warda A; Staniszewski LJP; Sabir Z; Livingston S; Sausedo M; Reshi S; Ron E; Applegate MT; Haddad D; Khamisi M; Marshall PA; Wagner CE; Jurutka PW
    Cells; 2023 Nov; 12(21):. PubMed ID: 37947652
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
    Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Synthetic Retinoids Beyond cancer Therapy.
    Gudas LJ
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():155-175. PubMed ID: 34516292
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrated analysis of miRNA-mRNA networks reveals a strong anti-skin cancer signature in vitiligo epidermis.
    Singh A; Gupta A; Chowdhary M; Brahmbhatt HD
    Exp Dermatol; 2021 Sep; 30(9):1309-1319. PubMed ID: 33682215
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Disparate roles of retinoid acid signaling molecules in kidney disease.
    Chen A; Liu Y; Lu Y; Lee K; He JC
    Am J Physiol Renal Physiol; 2021 May; 320(5):F683-F692. PubMed ID: 33645319
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Investigation of TNF-α and IL-6 Levels in the Sera of Non-Melanoma skin cancer Patients.
    Ghahartars M; Abtahi S; Zeinali Z; Fattahi MJ; Ghaderi A
    Iran Biomed J; 2021 Mar; 25(2):88-92. PubMed ID: 33461943
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic Predictors of Severe skin Toxicity in Patients with Stage III Colon cancer Treated with Cetuximab: NCCTG N0147 (Alliance).
    Labadie JD; Hua X; Harrison TA; Banbury BL; Huyghe JR; Sun W; Shi Q; Yothers G; Alberts SR; Sinicrope FA; Goldberg RM; George TJ; Penney KL; Phipps AI; Cohen SA; Peters U; Chan AT; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):404-411. PubMed ID: 33203692
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Characterizing therapeutic signatures of transcription factors in cancer by incorporating profiles in compound treated cells.
    Jung J
    Bioinformatics; 2021 May; 37(7):1008-1014. PubMed ID: 32886093
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Monotherapy and combination therapy with acitretin for mycosis fungoides: results of a retrospective, multicentre study.
    Nikolaou V; Patsatsi A; Sidiropoulou P; Chlouverakis G; Kavvalou E; Koletsa T; Economidi A; Georgiou E; Papadavid E; Rigopoulos D; Stratigos AJ; Kruger-Krasagakis SE
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2534-2540. PubMed ID: 32364303
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Self-Assembly Of Retinoid Nanoparticles For Melanoma Therapy.
    Liao H; Zhao S; Wang H; Liu Y; Zhang Y; Sun G
    Int J Nanomedicine; 2019; 14():7963-7973. PubMed ID: 31632011
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Adapalene suppressed the proliferation of melanoma cells by S-phase arrest and subsequent apoptosis via induction of DNA damage.
    Li H; Wang C; Li L; Bu W; Zhang M; Wei J; Tao L; Qian K; Ma P
    Eur J Pharmacol; 2019 May; 851():174-185. PubMed ID: 30836068
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis.
    Guo Y; Long J; Lei S
    J Cell Physiol; 2019 May; 234(5):7356-7367. PubMed ID: 30370527
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Effects of 9-cis-retinoic acid on the proliferation and apoptosis of cutaneous T-cell lymphoma cells.
    Yang H; Tao Y; Zhang M; Ma P; Li L; Diao Q
    Anticancer Drugs; 2019 Jan; 30(1):56-64. PubMed ID: 30198914
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Retinoic acid receptor agonist as monotherapy for early-stage mycosis fungoides: does it work?
    Amitay-Laish I; Reiter O; Prag-Naveh H; Kershenovich R; Hodak E
    J Dermatolog Treat; 2019 May; 30(3):258-263. PubMed ID: 29889596
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A rare Case of Relapsed Pediatric Acute Promyelocytic Leukemia with skin Involvement by Myeloid Sarcoma.
    Araújo NS; Dos Santos Júnior CJ; Gomes VMDS; Calheiros Leite LA; Bomfim LN; Gusmão AKFDS; Alves MJRG; Romão CMDSB; Batinga AMCS; da Silva MR; de Sousa Rodrigues CF
    Am J Case Rep; 2018 Apr; 19():438-441. PubMed ID: 29650946
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Inhibition of cancer stem cell like cells by a synthetic retinoid.
    Chen J; Cao X; An Q; Zhang Y; Li K; Yao W; Shi F; Pan Y; Jia Q; Zhou W; Yang F; Wei F; Wang N; Yu B
    Nat Commun; 2018 Apr; 9(1):1406. PubMed ID: 29643385
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E).
    Park J; Yang J; Wenzel AT; Ramachandran A; Lee WJ; Daniels JC; Kim J; Martinez-Escala E; Amankulor N; Pro B; Guitart J; Mendillo ML; Savas JN; Boggon TJ; Choi J
    Blood; 2017 Sep; 130(12):1430-1440. PubMed ID: 28694326
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Human Hairless Protein Roles in skin/Hair and Emerging Connections to Brain and Other cancers.
    Maatough A; Whitfield GK; Brook L; Hsieh D; Palade P; Hsieh JC
    J Cell Biochem; 2018 Jan; 119(1):69-80. PubMed ID: 28543886
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. ECPIRM, a Potential Therapeutic Agent for Cutaneous T-Cell Lymphoma, Inhibits Cell Proliferation and Promotes Apoptosis via a JAK/STAT Pathway.
    Yang H; Ma P; Cao Y; Zhang M; Li L; Wei J; Tao L; Qian K
    Anticancer Agents Med Chem; 2018; 18(3):401-411. PubMed ID: 28356009
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.
    Reichrath J; Zouboulis CC; Vogt T; Holick MF
    Rev Endocr Metab Disord; 2016 Sep; 17(3):405-417. PubMed ID: 27447175
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.